Bresolin N, Doriguzzi C, Ponzetto C et al. (1990) Ubidecarenone in the treatment of mitochondrial myopathies: A multi-center double-blind trial. Journal of the Neurological Sciences 100 (1–2): 70–78

Chen RS, Huang CC, Chu N S (1997) Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study. European neurology 37 (4): 212–18

Glover EI, Martin J, Maher A et al. (2010) A randomized trial of coenzyme Q10 in mitochondrial disorders. Muscle and Nerve 42 (5): 739–48

Montini G, Malaventura C, Salviati L. (2008) Early coenzyme Q10 supplementation in primary coenzyme Q10 deficiency. New England Journal of Medicine 358 (26): 2849–50

Papadimitriou A, Hadjigeorgiou G M, Divari R et al. (1996) The influence of coenzyme Q10 on total serum calcium concentration in two patients with Kearns-Sayre Syndrome and hypoparathyroidism. Neuromuscular Disorders 6 (1): 49–53

Pfeffer G, Majamaa K, Turnbull D M et al. (2012) Treatment for mitochondrial disorders (review). Cochrane Database of Systematic Reviews Issue 4. No: CD004426

Rotig A, Appelkvist EL, Geromel V et al. (2000) Quinone-responsive multiple respiratory chain deficiency due to widespread coenzyme Q10 deficiency. Lancet 356 (9227): 391–95

Salviati L, Sacconi S, Murer L, et al. (2005) Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: a CoQ10-responsive condition. Neurology 65 (4): 606–08